Issue Date | Title | Author(s) |
2021-09-29 | Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease. | Finkelstein, DI; Billings, JL; Adlard, PA; Ayton, S; Sedjahtera, A; Masters, CL; Wilkins, S; Shackleford, DM; Charman, SA; Bal, W; Zawisza, IA; Kurowska, E; Gundlach, AL; Ma, S; Bush, AI; Hare, DJ; Doble, PA; Crawford, S; Gautier, ECL; Parsons, J; Huggins, P; Barnham, KJ; Cherny, RA |
2017-06-28 | The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease | Finkelstein, DI; Billings, JL; Adlard, PA; Ayton, S; Sedjahtera, A; Masters, CL; Wilkins, S; Shackleford, DM; Charman, SA; Bal, W; Zawisza, IA; Kurowska, E; Gundlach, AL; Ma, S; Bush, AI; Hare, DJ; Doble, PA; Crawford, S; Gautier, EC; Parsons, J; Huggins, P; Barnham, KJ; Cherny, RA |
2014-01-01 | Oral treatment with Cu<sup>II</sup>(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis | Roberts, BR; Lim, NKH; McAllum, EJ; Donnelly, PS; Hare, DJ; Doble, PA; Turner, BJ; Price, KA; Lim, SC; Paterson, BM; Hickey, JL; Rhoads, TW; Williams, JR; Kanninen, KM; Hung, LW; Liddell, JR; Grubman, A; Monty, JF; Llanos, RM; Kramer, DR; Mercer, JFB; Bush, AI; Masters, CL; Duce, JA; Li, QX; Beckman, JS; Barnham, KJ; White, AR; Crouch, PJ |
2015-01-01 | Stabilization of nontoxic Ajβ-oligomers: Insights into the mechanism of action of hydroxyquinolines in alzheimer’s disease | Ryan, TM; Roberts, BR; McColl, G; Hare, DJ; Doble, PA; Li, QX; Lind, M; Roberts, AM; Mertens, HDT; Kirb, N; Pham, CLL; Hinds, MG; Adlard, PA; Barnham, KJ; Curtain, CC; Masters, CL |